Private / Strategic
15 Nov 2026–15 Dec 2026
10% Released At TGE. 3-Month Cliff. Remaining 90% Vesting Over 12 Months.

AVX is the fixed-supply utility token inside the Avirox Labs ecosystem, designed to support eligible ecosystem functions and participation pathways as they become ready.
Private / Strategic
15 Nov – 15 Dec 2026
50M AVX
$0.015 / AVX
Public Round 1
16 Dec 2026 – 15 Jan 2027
150M AVX
$0.020 / AVX
Public Round 2
16 Jan – 15 Feb 2027
100M AVX
$0.030 / AVX
Bar Height Reflects Price Per AVX
TGE IN
Founder Allocation
0%At TGE
0% Of The Founder Allocation Is Released At TGE, With A 12-Month Cliff And Remaining Tokens Vesting Over 36 Months.
15 Nov 2026–15 Dec 2026
10% Released At TGE. 3-Month Cliff. Remaining 90% Vesting Over 12 Months.
16 Dec 2026–15 Jan 2027
20% Released At TGE. Remaining 80% Vesting Over 6 Months.
16 Jan 2027–15 Feb 2027
25% Released At TGE. Remaining 75% Vesting Over 3 Months.
Avirox Labs and AVX support participation across the broader ecosystem, while Avirox Inc. operates independently as the enterprise product company. Enterprise customers can access Avirox Inc. products and services without holding or using AVX.
AVX does not provide ownership, control or governance rights over Avirox Inc., its customers, data or enterprise operations.